Analyst Ratings for Idera Pharmaceuticals (IDRA)

IDRA Rating Summary

  |   Expand Research on IDRA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/19/2021 Wedbush Robert Driscoll Downgrade Neutral
(Outperform)		 N/A
(N/A)		 5.21
(0.43)		 -91.75% Details
3/19/2021 Barclays Gena Wang Downgrade Equalweight
(Overweight)		 2.00
(N/A)		 5.13
(0.43)		 -91.62% Details